Regorafenib in advanced solitary fibrous tumour: results from an exploratory phase ii clinical study

To investigate the activity of regorafenib in advanced solitary fibrous tumour (SFT).
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research